Novocure Announces Data Presentations at the American Society for Radiation Oncology’s 2017 Annual Meeting
Late-breaking oral presentation to focus on Optune five-year survival and health-related quality of life data
ST. HELIER, Jersey–(BUSINESS WIRE)–
“We are excited to have a variety of research on TTFields presented at ASTRO’s 2017 Annual Meeting,” said Dr.
The following will be presented at the ASTRO 2017 Annual Meeting:
Late-breaking oral presentation
(LBA-6) Tumor Treating Fields (TTFields) – A novel cancer treatment modality: Translating preclinical evidence and engineering into a survival benefit with delayed decline in quality of life. R. Stupp. 3:15 –
Oral presentation
(68) Tumor Treating Fields (TTFields) Delay DNA Damage Repair Following Radiation Treatment of Glioma Cells: Implications for Irradiation through TTFields Transducer Arrays. M. Story.
Poster presentation
(3530) Creating patient-specific computational head models for the study of tissue-electric field interactions using deformable templates. N. Urman.
(3529) Measuring the electric properties of human skin in order to understand how Tumor Treating Fields distribute within the body. H. Hershkovich.
About
Headquartered in Jersey,
Forward-Looking Statements
In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Forward-looking statements provide Novocure’s current expectations or forecasts of future events. These may include statements regarding anticipated scientific progress on its research programs, development of potential products, interpretation of clinical results, prospects for regulatory approval, manufacturing development and capabilities, market prospects for its products, and other statements regarding matters that are not historical facts. You may identify some of these forward-looking statements by the use of words in the statements such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” or other words and terms of similar meaning. Novocure’s performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, regulatory and political conditions as well as more specific risks and uncertainties facing
View source version on businesswire.com: http://www.businesswire.com/news/home/20170922005283/en/
Source:
Media and Investors:
Novocure
Ashley Cordova, 212-767-7558
acordova@novocure.com